Biocon Limited — JV/Acquisition, 03-03-2026: Acquisition

Biocon has injected **Rs 315.34 Cr** into its wholly-owned subsidiaries, Biocon Biosphere Limited (BBSL) and Biocon Pharma Limited (BPL), by acquiring Preference Shares. BBSL received **Rs 115.34 Cr** for its API & generic formulations business, while BPL secured **Rs 200 Cr** for its global generic formulations development. This strategic capital infusion will fund ongoing business needs, including working capital and capital expenditure, reinforcing Biocon's growth engines in key pharmaceutical segments and ensuring continued expansion.